A HISTORIC COMPANY MILESTONE

Myonex is proud to announce that we opened our brand new, state-of-the-art Global Headquarters in Horsham, Pennsylvania in September 2021. 


Set on 14-acres, the 65,000-square-foot GMP facility gives us the space we need to continue to grow and expand our service offerings, with more room for cold storage and secure storage of controlled substances, document storage, flexible GMP labeling rooms and many other features designed to enable us to respond quickly to customer requirements.

Our new facility not only supports our growing employee base, but also anticipates future growth and service offerings based on our clients’ needs. From expanding our service offerings with Clinical Trial Patient Solutions and Clinical Trial Equipment and Supplies to constantly growing our team, this facility will be able to meet all of our needs as well as our clients’ needs. Our impressive 65,000 square foot facility has state-of-the-art workstations, huddle rooms for team collaboration, and so much more!

Today, with a new headquarters in the United States, an expanded facility in the United Kingdom, and partnership in continental Europe, Myonex offers end-to-end services and tailored solutions for most situations.

TAKE A LOOK AT OUR NEW FACILITY

Our temperature-controlled

45,000 sq. ft. warehouse includes: 

  • a 4,250 sq. ft. cold storage room that can hold up to 344 pallets and can store drugs at 2-8°C in the refrigerated section or -20°C in the freezer section
  • three -80°C stand-alone freezers
  • a 185 sq. ft. controlled substances vault which is DEA compliant
  • four temperature-controlled rooms designated for secondary packaging and labeling

Our temperature-controlled 45,000 sq. ft. warehouse includes: 

  • a 4,250 sq. ft. cold storage room that can hold up to 344 pallets and can store drugs at 2-8°C in the refrigerated section or -20°C in the freezer section
  • three -80°C stand-alone freezers
  • a 185 sq. ft. controlled substances vault which is DEA compliant
  • four temperature-controlled rooms designated for secondary packaging and labeling

With Myonex as your clinical trial supply partner, you’ll gain…

  • expert problem-solving and tailored solutions for any challenge 
  • speedy access to the right supply of drugs so the trial can start on time
  • tools for reducing overage to eliminate waste 
  • flexibility to change drug supply requests 
  • ways to reduce costs 
  • answers to your inquiries

Experience the simplicity of working with a single vendor 
who can handle:

  • comparator drug sourcing and supply
  • packaging and distribution 
  • returning or redistributing unused drugs
  • providing all equipment and supplies needed for the trial, from IVs and tubing to refrigeration — and everything in between.

Let’s discuss how we can help you plan your next global clinical trial.

Go to article: Home | Unpacking innovation in biologics Go to article: In this issueGo to article: ContentsGo to article: MyonexGo to article: Controlant Company InsightGo to article: ControlantGo to article: SHL MedicalGo to article: LabcorpGo to article: ReutersGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: TQS Integration Company InsightGo to article: TQS IntergrationGo to article: Biesterfeld Go to article: CommentGo to article: Biotech and China: a global opportunityGo to article: Intranasal ketamine could effectively treat phantom painGo to article: EU biosimilar wave slows as biosimilar approvals decrease in the EUGo to article: Biosynth Carbosynth Company InsightGo to article: Biosynth CarbosynthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: SkyepharmaGo to article: In DepthGo to article: Unpacking the complex challenge of biologicsGo to article: Living medicines: using bacteria to fight cancerGo to article: The marred history of HIV vaccine trialsGo to article: Has Covid-19 exposed the weakness of the US pharma supply chain?Go to article: How the pandemic pushed pharmacovigilance to innovateGo to article: ExeVir: the llama-derived antibody that could fight Covid-19Go to article: BEA TechnologiesGo to article: WatlowGo to article: DuojectGo to article: ButterworthGo to article: In DataGo to article: Data: Big Data hiring efforts in pharmaGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue